Colgate (CLGT) reported another weak quarter of results, with sales/EBITDA/PAT growth in the 24% range. In addition to weak sales growth, material cost pressures are evident; margins came in marginally below estimates despite the sharp 24% cut in ad spends YoY. We maintain a Neutral rating as we do not see any valuation re-rating unless the sales growth traction returns....